<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36857178</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2211-1247</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>28</Day></PubDate></JournalIssue><Title>Cell reports</Title><ISOAbbreviation>Cell Rep</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice.</ArticleTitle><Pagination><StartPage>112189</StartPage><MedlinePgn>112189</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2023.112189</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2211-1247(23)00200-0</ELocationID><Abstract><AbstractText>Cognitive dysfunction is often reported in patients with post-coronavirus disease 2019 (COVID-19) syndrome, but its underlying mechanisms are not completely understood. Evidence suggests that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike protein or its fragments are released from cells during infection, reaching different tissues, including the CNS, irrespective of the presence of the viral RNA. Here, we demonstrate that brain infusion of Spike protein in mice has a late impact on cognitive function, recapitulating post-COVID-19 syndrome. We also show that neuroinflammation and hippocampal microgliosis mediate Spike-induced memory dysfunction via complement-dependent engulfment of synapses. Genetic or pharmacological blockage of Toll-like receptor 4 (TLR4) signaling protects animals against synapse elimination and memory dysfunction induced by Spike brain infusion. Accordingly, in a cohort of 86 patients who recovered from mild COVID-19, the genotype GG TLR4-2604G&gt;A (rs10759931) is associated with poor cognitive outcome. These results identify TLR4 as a key target to investigate the long-term cognitive dysfunction after COVID-19 infection in humans and rodents.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fontes-Dantas</LastName><ForeName>Fabricia L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Department of Pharmacology, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Gabriel G</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutman</LastName><ForeName>Elisa G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Translational Neuroscience Laboratory (LabNet), Post-Graduate Program in Neurology, Federal University of Rio de Janeiro State, Rio de Janeiro, RJ, Brazil; Clinical Medicine Post-graduation Program, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Lima</LastName><ForeName>Emanuelle V</ForeName><Initials>EV</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonio</LastName><ForeName>Leticia S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammerle</LastName><ForeName>Mariana B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Clinical Medicine Post-graduation Program, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mota-Araujo</LastName><ForeName>Hannah P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colodeti</LastName><ForeName>Lilian C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ara&#xfa;jo</LastName><ForeName>Suzana M B</ForeName><Initials>SMB</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Froz</LastName><ForeName>Gabrielle M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Talita N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Larissa A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Translational Neuroscience Laboratory (LabNet), Post-Graduate Program in Neurology, Federal University of Rio de Janeiro State, Rio de Janeiro, RJ, Brazil; Clinical Medicine Post-graduation Program, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvio</LastName><ForeName>Andreza L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Translational Neuroscience Laboratory (LabNet), Post-Graduate Program in Neurology, Federal University of Rio de Janeiro State, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pires</LastName><ForeName>Karina L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Neurology Department, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leon</LastName><ForeName>Luciane A A</ForeName><Initials>LAA</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Desenvolvimento Tecnol&#xf3;gico em Virologia, IOC/FIOCRUZ, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasconcelos</LastName><ForeName>Claudia Cristina F</ForeName><Initials>CCF</Initials><AffiliationInfo><Affiliation>Neurology Department, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rom&#xe3;o</LastName><ForeName>Luciana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savio</LastName><ForeName>Luiz Eduardo B</ForeName><Initials>LEB</Initials><AffiliationInfo><Affiliation>Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Jerson L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Costa</LastName><ForeName>Robson</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Julia R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Da Poian</LastName><ForeName>Andrea T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Electronic address: dapoian@bioqmed.ufrj.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alves-Leon</LastName><ForeName>Soniza V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Translational Neuroscience Laboratory (LabNet), Post-Graduate Program in Neurology, Federal University of Rio de Janeiro State, Rio de Janeiro, RJ, Brazil; Division of Neurology, Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Electronic address: sonizavieiraalvesleon@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Passos</LastName><ForeName>Giselle F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Electronic address: gfazzioni@yahoo.com.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figueiredo</LastName><ForeName>Claudia P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Electronic address: claudia@pharma.ufrj.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep</MedlineTA><NlmUniqueID>101573691</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051197">Toll-Like Receptor 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495345">TLR4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C493487">Tlr4 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051197" MajorTopicYN="N">Toll-Like Receptor 4</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CP: Immunology</Keyword><Keyword MajorTopicYN="N">CP: Neuroscience</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 spike protein</Keyword><Keyword MajorTopicYN="N">TLR4</Keyword><Keyword MajorTopicYN="N">cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">genetic variant</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">microgliosis</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">synapse loss</Keyword><Keyword MajorTopicYN="N">synaptic pruning</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>1</Day><Hour>12</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36857178</ArticleId><ArticleId IdType="pmc">PMC9935273</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2023.112189</ArticleId><ArticleId IdType="pii">S2211-1247(23)00200-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lamers M.M., Haagmans B.L. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 2022;20:270&#x2013;284. doi: 10.1038/s41579-022-00713-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782&#x2013;793. doi: 10.1001/jama.2020.12839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., Mendel J., Camplisson I., Dercon Q., Harrison P.J. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatr. 2022;9:815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7&#xa0;months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.-E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J.&#xa0;Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Etter M.M., Martins T.A., Kulsvehagen L., P&#xf6;ssnecker E., Duchemin W., Hogan S., Sanabria-Diaz G., M&#xfc;ller J., Chiappini A., Rychen J., et al. Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat. Commun. 2022;13:6777. doi: 10.1038/s41467-022-34068-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34068-0</ArticleId><ArticleId IdType="pmc">PMC9645766</ArticleId><ArticleId IdType="pubmed">36351919</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo G.D., Lazarini F., Levallois S., Hautefort C., Michel V., Larrous F., Verillaud B., Aparicio C., Wagner S., Gheusi G., et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 2021;13:eabf8396. doi: 10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I., Mayer M.G., Hellmers L.M., Ning B., Huang Z., Monjure C.J., Coyne C., Silvestri R., Golden N., Hensley K., et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat. Commun. 2022;13:1745. doi: 10.1038/s41467-022-29440-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Laksono B.M., de Vrij F.M.S., Kushner S.A., Harschnitz O., van Riel D. The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2. Trends Neurosci. 2022;45:358&#x2013;368. doi: 10.1016/j.tins.2022.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-weber H., Schroeder S., Mu M.A., Drosten C., Po S., Hoffmann M., Kleine-weber H., Schroeder S., Kru N. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven article SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko C.J., Harigopal M., Gehlhausen J.R., Bosenberg M., McNiff J.M., Damsky W. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein. J.&#xa0;Cutan. Pathol. 2021;48:47&#x2013;52. doi: 10.1111/cup.13866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cup.13866</ArticleId><ArticleId IdType="pubmed">32895985</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., Sperhake J.P., Schr&#xf6;der A.S., Edler C., Mushumba H., Fitzek A., Allweiss L., Dandri M., et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer Z., Alhusaini N., Tabler C.O., Sweet T., de Carvalho K.I.L., Schlatzer D.M., Carias L., King C.L., Matreyek K., Tilton J.C. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies. J.&#xa0;Extracell. Vesicles. 2021;10:e12112. doi: 10.1002/jev2.12112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12112</ArticleId><ArticleId IdType="pmc">PMC8213968</ArticleId><ArticleId IdType="pubmed">34188786</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea E.M., Logsdon A.F., Hansen K.M., Williams L.M., Reed M.J., Baumann K.K., Holden S.J., Raber J., Banks W.A., Erickson M.A. The S1 protein of SARS-CoV-2 crosses the blood&#x2013;brain barrier in mice. Nat. Neurosci. 2021;24:368&#x2013;378. doi: 10.1038/s41593-020-00771-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin. Infect. Dis. 2022;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T., Kawai T. Toll-like receptor signaling pathways. Front. Immunol. 2014;5:461. doi: 10.3389/fimmu.2014.00461.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00461</ArticleId><ArticleId IdType="pmc">PMC4174766</ArticleId><ArticleId IdType="pubmed">25309543</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya M., Sharma A.R., Mallick B., Sharma G., Lee S.-S., Chakraborty C. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex. Infect. Genet. Evol. 2020;85:104587. doi: 10.1016/j.meegid.2020.104587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2020.104587</ArticleId><ArticleId IdType="pmc">PMC7543713</ArticleId><ArticleId IdType="pubmed">33039603</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A., Mukherjee S. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J.&#xa0;Med. Virol. 2020;92:2105&#x2013;2113. doi: 10.1002/jmv.25987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25987</ArticleId><ArticleId IdType="pmc">PMC7267663</ArticleId><ArticleId IdType="pubmed">32383269</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboudounya M.M., Heads R.J. COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. Mediat. Inflamm. 2021;2021:8874339. doi: 10.1155/2021/8874339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8874339</ArticleId><ArticleId IdType="pmc">PMC7811571</ArticleId><ArticleId IdType="pubmed">33505220</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank M.G., Nguyen K.H., Ball J.B., Hopkins S., Kelley T., Baratta M.V., Fleshner M., Maier S.F. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: evidence of PAMP-like properties. Brain Behav. Immun. 2022;100:267&#x2013;277. doi: 10.1016/j.bbi.2021.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.007</ArticleId><ArticleId IdType="pmc">PMC8667429</ArticleId><ArticleId IdType="pubmed">34915155</ArticleId></ArticleIdList></Reference><Reference><Citation>Olajide O.A., Iwuanyanwu V.U., Adegbola O.D., Al-Hindawi A.A. SARS-CoV-2 spike glycoprotein S1 induces neuroinflammation in BV-2 microglia. Mol. Neurobiol. 2022;59:445&#x2013;458. doi: 10.1007/s12035-021-02593-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02593-6</ArticleId><ArticleId IdType="pmc">PMC8551352</ArticleId><ArticleId IdType="pubmed">34709564</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Kuang M., Li J., Zhu L., Jia Z., Guo X., Hu Y., Kong J., Yin H., Wang X., You F. SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res. 2021;31:818&#x2013;820. doi: 10.1038/s41422-021-00495-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00495-9</ArticleId><ArticleId IdType="pmc">PMC7975240</ArticleId><ArticleId IdType="pubmed">33742149</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Wise L., Fukuchi K.-I. TLR4 cross-talk with NLRP3 inflammasome and complement signaling pathways in Alzheimer&#x2019;s disease. Front. Immunol. 2020;11:724. doi: 10.3389/fimmu.2020.00724.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00724</ArticleId><ArticleId IdType="pmc">PMC7190872</ArticleId><ArticleId IdType="pubmed">32391019</ArticleId></ArticleIdList></Reference><Reference><Citation>Albornoz E.A., Amarilla A.A., Modhiran N., Parker S., Li X.X., Wijesundara D.K., Aguado J., Zamora A.P., McMillan C.L.D., Liang B., et al. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. Mol. Psychiatr. 2022 doi: 10.1038/s41380-022-01831-0. Preprint at.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01831-0</ArticleId><ArticleId IdType="pmc">PMC10615762</ArticleId><ArticleId IdType="pubmed">36316366</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirato K., Kizaki T. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon. 2021;7:e06187. doi: 10.1016/j.heliyon.2021.e06187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2021.e06187</ArticleId><ArticleId IdType="pmc">PMC7887388</ArticleId><ArticleId IdType="pubmed">33644468</ArticleId></ArticleIdList></Reference><Reference><Citation>Theobald S.J., Simonis A., Georgomanolis T., Kreer C., Zehner M., Eisfeld H.S., Albert M.-C., Chhen J., Motameny S., Erger F., et al. Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19. EMBO Mol. Med. 2021;13:e14150. doi: 10.15252/emmm.202114150.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114150</ArticleId><ArticleId IdType="pmc">PMC8350892</ArticleId><ArticleId IdType="pubmed">34133077</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.S., Jeon M.-T., Kim K.-S., Lee S., Kim S., Kim D.-G. Spike proteins of SARS-CoV-2 induce pathological changes in molecular delivery and metabolic function in the brain endothelial cells. Viruses. 2021;13:102021. doi: 10.3390/v13102021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13102021</ArticleId><ArticleId IdType="pmc">PMC8538996</ArticleId><ArticleId IdType="pubmed">34696455</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J.J., Serafini R.A., Pryce K.D., Zazhytska M., Oishi K., Golynker I., Panis M., Zimering J., Horiuchi S., Hoagland D.A., et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci. Transl. Med. 2022;14:eabq3059. doi: 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnon K.H., 3rd, Leist S.R., Okuda K., Dang H., Fritch E.J., Gully K.L., De la Cruz G., Evangelista M.D., Asakura T., Gilmore R.C., et al. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice. Sci. Transl. Med. 2022;14:eabo5070. doi: 10.1126/scitranslmed.abo5070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abo5070</ArticleId><ArticleId IdType="pmc">PMC9273046</ArticleId><ArticleId IdType="pubmed">35857635</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueiredo C.P., Barros-Arag&#xe3;o F.G.Q., Neris R.L.S., Frost P.S., Soares C., Souza I.N.O., Zeidler J.D., Zamberlan D.C., de Sousa V.L., Souza A.S., et al. Zika virus replicates in adult human brain tissue and impairs synapses and memory in mice. Nat. Commun. 2019;10:3890. doi: 10.1038/s41467-019-11866-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11866-7</ArticleId><ArticleId IdType="pmc">PMC6728367</ArticleId><ArticleId IdType="pubmed">31488835</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea E.M., Logsdon A.F., Hansen K.M., Williams L.M., Reed M.J., Baumann K.K., Holden S.J., Raber J., Banks W.A., Erickson M.A. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat. Neurosci. 2021;24:368&#x2013;378. doi: 10.1038/s41593-020-00771-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., Meunier N., Bryche B., von Bartheld C.S. The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models. Acta Neuropathol. 2021;141:809&#x2013;822. doi: 10.1007/s00401-021-02314-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02314-2</ArticleId><ArticleId IdType="pmc">PMC8075028</ArticleId><ArticleId IdType="pubmed">33903954</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Br&#xfc;nink S., Greuel S., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K., von Bartheld C.S., Butowt R. Expression of the ACE2 virus entry protein in the nervus terminalis reveals the potential for an alternative route to brain infection in COVID-19. Front. Cell. Neurosci. 2021;15:674123. doi: 10.3389/fncel.2021.674123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.674123</ArticleId><ArticleId IdType="pmc">PMC8287262</ArticleId><ArticleId IdType="pubmed">34290590</ArticleId></ArticleIdList></Reference><Reference><Citation>Patr&#xec; A., Vargas M., Buonanno P., Annunziata M.C., Russo D., Staibano S., Servillo G., Fabbrocini G. From SARS-CoV-2 hematogenous spreading to endothelial dysfunction: clinical-histopathological study of cutaneous signs of COVID-19. Diagn. Pathol. 2021;16:16. doi: 10.1186/s13000-021-01075-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13000-021-01075-6</ArticleId><ArticleId IdType="pmc">PMC7905980</ArticleId><ArticleId IdType="pubmed">33632250</ArticleId></ArticleIdList></Reference><Reference><Citation>Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 2006;1:848&#x2013;858. doi: 10.1038/nprot.2006.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.116</ArticleId><ArticleId IdType="pmc">PMC2895266</ArticleId><ArticleId IdType="pubmed">17406317</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S., Beja-Glasser V.F., Nfonoyim B.M., Frouin A., Li S., Ramakrishnan S., Merry K.M., Shi Q., Rosenthal A., Barres B.A., et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712&#x2013;716. doi: 10.1126/science.aad8373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad8373</ArticleId><ArticleId IdType="pmc">PMC5094372</ArticleId><ArticleId IdType="pubmed">27033548</ArticleId></ArticleIdList></Reference><Reference><Citation>Colom-Cadena M., Spires-Jones T., Zetterberg H., Blennow K., Caggiano A., DeKosky S.T., Fillit H., Harrison J.E., Schneider L.S., Scheltens P., et al. The clinical promise of biomarkers of synapse damage or loss in Alzheimer&#x2019;s disease. Alzheimer's Res. Ther. 2020;12:21. doi: 10.1186/s13195-020-00588-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00588-4</ArticleId><ArticleId IdType="pmc">PMC7053087</ArticleId><ArticleId IdType="pubmed">32122400</ArticleId></ArticleIdList></Reference><Reference><Citation>Shives K.D., Tyler K.L., Beckham J.D. Molecular mechanisms of neuroinflammation and injury during acute viral encephalitis. J.&#xa0;Neuroimmunol. 2017;308:102&#x2013;111. doi: 10.1016/j.jneuroim.2017.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2017.03.006</ArticleId><ArticleId IdType="pubmed">28291542</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Zhong D., Li G. The role of microglia in viral encephalitis: a review. J.&#xa0;Neuroinflammation. 2019;16:76. doi: 10.1186/s12974-019-1443-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1443-2</ArticleId><ArticleId IdType="pmc">PMC6454758</ArticleId><ArticleId IdType="pubmed">30967139</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasek M.J., Garber C., Dorsey D., Durrant D.M., Bollman B., Soung A., Yu J., Perez-Torres C., Frouin A., Wilton D.K., et al. A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature. 2016;534:538&#x2013;543. doi: 10.1038/nature18283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18283</ArticleId><ArticleId IdType="pmc">PMC5452615</ArticleId><ArticleId IdType="pubmed">27337340</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164&#x2013;1178. doi: 10.1016/j.cell.2007.10.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.10.036</ArticleId><ArticleId IdType="pubmed">18083105</ArticleId></ArticleIdList></Reference><Reference><Citation>Miron J., Picard C., Lafaille-Magnan M.&#xc9;., Savard M., Labont&#xe9; A., Breitner J., Rosa-Neto P., Auld D., Poirier J., PREVENT-AD research group Association of TLR4 with Alzheimer&#x2019;s disease risk and presymptomatic biomarkers of inflammation. Alzheimers Dement. 2019;15:951&#x2013;960. doi: 10.1016/j.jalz.2019.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.03.012</ArticleId><ArticleId IdType="pubmed">31175027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ed&#xe9;n A., Kanberg N., Gostner J., Fuchs D., Hagberg L., Andersson L.-M., Lindh M., Price R.W., Zetterberg H., Gissl&#xe9;n M. CSF biomarkers in patients with COVID-19 and neurologic symptoms: a case series. Neurology. 2021;96:e294&#x2013;e300. doi: 10.1212/WNL.0000000000010977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010977</ArticleId><ArticleId IdType="pubmed">33004602</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Masciocchi S., Volonghi I., De Giuli V., Caprioli F., Mariotto S., Ferrari S., Bozzetti S., Imarisio A., Risi B., et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses. Clin. Infect. Dis. 2021;73:e3019&#x2013;e3026. doi: 10.1093/cid/ciaa1933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1933</ArticleId><ArticleId IdType="pmc">PMC7799260</ArticleId><ArticleId IdType="pubmed">33395482</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B., Tang N., Peluso M.J., Iyer N.S., Torres L., Donatelli J.L., Munter S.E., Nixon C.C., Rutishauser R.L., Rodriguez-Barraquer I., et al. Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells. 2021;10:e020386. doi: 10.3390/cells10020386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay M., Ryan L., Huentelman M., Konhilas J., Hoyer-Kimura C., Beach T.G., Serrano G.E., Reiman E.M., Blennow K., Zetterberg H., Parthasarathy S. Serum neurofilament light is elevated in COVID-19 positive adults in the ICU and is associated with Co-morbid cardiovascular disease, neurological complications, and acuity of illness. Cardiol. Cardiovasc. Med. 2021;5:551&#x2013;565. doi: 10.26502/fccm.92920221.</Citation><ArticleIdList><ArticleId IdType="doi">10.26502/fccm.92920221</ArticleId><ArticleId IdType="pmc">PMC8547787</ArticleId><ArticleId IdType="pubmed">34708189</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Erben Y., Marquez C.P., Jansen-West K.R., Franco-Mesa C., Heckman M.G., White L.J., Dunmore J.A., Cook C.N., Lilley M.T., et al. Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19. Sci. Transl. Med. 2021;13:eabi7643. doi: 10.1126/scitranslmed.abi7643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abi7643</ArticleId><ArticleId IdType="pmc">PMC8432951</ArticleId><ArticleId IdType="pubmed">34131052</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.-C., Yip P.-K., Huang Y.-L., Sun Y., Wen L.-L., Chu Y.-M., Chen T.-F. Sequence variants of toll like receptor 4 and late-onset Alzheimer&#x2019;s disease. PLoS One. 2012;7:e50771. doi: 10.1371/journal.pone.0050771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0050771</ArticleId><ArticleId IdType="pmc">PMC3525588</ArticleId><ArticleId IdType="pubmed">23272070</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J.-T., Miao D., Cui W.-Z., Ou J.-R., Tian Y., Wu Z.-C., Zhang W., Tan L. Common variants in toll-like receptor 4 confer susceptibility to Alzheimer&#x2019;s disease in a Han Chinese population. Curr. Alzheimer Res. 2012;9:458&#x2013;466. doi: 10.2174/156720512800492495.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720512800492495</ArticleId><ArticleId IdType="pubmed">22272615</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.-Z., Yu J.-T., Miao D., Wu Z.-C., Zong Y., Wen C.-Q., Tan L. Genetic association of TLR4/11367 polymorphism with late-onset Alzheimer&#x2019;s disease in a Han Chinese population. Brain Res. 2011;1381:202&#x2013;207. doi: 10.1016/j.brainres.2011.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.01.007</ArticleId><ArticleId IdType="pubmed">21236243</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 2022;28:2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen A.K., Wang X., McCluskey L.P., Morgan J.C., Switzer J.A., Mehta R., Tingen M., Su S., Harris R.A., Hess D.C., Rutkowski E.K. Neuropsychiatric sequelae of long COVID-19: pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia, USA. Brain Behav. Immun. Health. 2022;24:100491. doi: 10.1016/j.bbih.2022.100491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100491</ArticleId><ArticleId IdType="pmc">PMC9290328</ArticleId><ArticleId IdType="pubmed">35873350</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacomy H., Fragoso G., Almazan G., Mushynski W.E., Talbot P.J. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice. Virology. 2006;349:335&#x2013;346. doi: 10.1016/j.virol.2006.01.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.01.049</ArticleId><ArticleId IdType="pmc">PMC7111850</ArticleId><ArticleId IdType="pubmed">16527322</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Li X., Geng D., Mei N., Wu P.-Y., Huang C.-C., Jia T., Zhao Y., Wang D., Xiao A., Yin B. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484. doi: 10.1016/j.eclinm.2020.100484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., Guis S., Barthelemy F., Habert P., Ceccaldi M., et al. (18 F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imag. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng G.-P., Feng Z., He F.-P., Chen Z.-Q., Liu X.-Y., Liu P., Luo B.-Y. Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer&#x2019;s disease. CNS Neurosci. Ther. 2015;21:15&#x2013;22. doi: 10.1111/cns.12317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12317</ArticleId><ArticleId IdType="pmc">PMC6495306</ArticleId><ArticleId IdType="pubmed">25146658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ystad M.A., Lundervold A.J., Wehling E., Espeseth T., Rootwelt H., Westlye L.T., Andersson M., Adolfsdottir S., Geitung J.T., Fjell A.M., et al. Hippocampal volumes are important predictors for memory function in elderly women. BMC Med. Imag. 2009;9:17. doi: 10.1186/1471-2342-9-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2342-9-17</ArticleId><ArticleId IdType="pmc">PMC2743662</ArticleId><ArticleId IdType="pubmed">19698138</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosconi L., De Santi S., Li J., Tsui W.H., Li Y., Boppana M., Laska E., Rusinek H., de Leon M.J. Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol. Aging. 2008;29:676&#x2013;692. doi: 10.1016/j.neurobiolaging.2006.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2006.12.008</ArticleId><ArticleId IdType="pmc">PMC2430185</ArticleId><ArticleId IdType="pubmed">17222480</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuovo G.J., Magro C., Shaffer T., Awad H., Suster D., Mikhail S., He B., Michaille J.-J., Liechty B., Tili E. Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein. Ann. Diagn. Pathol. 2021;51:151682. doi: 10.1016/j.anndiagpath.2020.151682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anndiagpath.2020.151682</ArticleId><ArticleId IdType="pmc">PMC7758180</ArticleId><ArticleId IdType="pubmed">33360731</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J., Cho W.-H., Barcelon E., Kim K.H., Hong J., Lee S.J. SARS-CoV-2 spike protein induces cognitive deficit and anxiety-like behavior in mouse via non-cell autonomous hippocampal neuronal death. Sci. Rep. 2022;12:5496. doi: 10.1038/s41598-022-09410-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09410-7</ArticleId><ArticleId IdType="pmc">PMC8970073</ArticleId><ArticleId IdType="pubmed">35361832</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng L., Bestard-Lorigados I., Song W. The synapse as a treatment avenue for Alzheimer&#x2019;s Disease. Mol. Psychiatr. 2022;27:2940&#x2013;2949. doi: 10.1038/s41380-022-01565-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01565-z</ArticleId><ArticleId IdType="pubmed">35444256</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossy-Wetzel E., Schwarzenbacher R., Lipton S.A. Molecular pathways to neurodegeneration. Nat. Med. 2004;10:S2&#x2013;S9. doi: 10.1038/nm1067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1067</ArticleId><ArticleId IdType="pubmed">15272266</ArticleId></ArticleIdList></Reference><Reference><Citation>Volmer R., Prat C.M.A., Le Masson G., Garenne A., Gonzalez-Dunia D. Borna disease virus infection impairs synaptic plasticity. J.&#xa0;Virol. 2007;81:8833&#x2013;8837. doi: 10.1128/JVI.00612-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00612-07</ArticleId><ArticleId IdType="pmc">PMC1951342</ArticleId><ArticleId IdType="pubmed">17553893</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira A.O., Malwade S., de Sousa N.R., Goparaju S.K., Lekander J.G., Orhan F., Steponaviciute L., Schalling M., Sheridan S.D., Perlis R.H., et al. SARS-CoV-2 promotes microglial synapse elimination in human brain organoids. bioRxiv. 2022 doi: 10.1101/2021.07.07.451463. Preprint at.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.07.451463</ArticleId><ArticleId IdType="pmc">PMC9533278</ArticleId><ArticleId IdType="pubmed">36198765</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.C., Kern F., Losada P.M., Agam M.R., Maat C.A., Schmartz G.P., Fehlmann T., Stein J.A., Schaum N., Lee D.P., et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan A., Sershen H., Basavarajappa B.S., Kumar A., Hashim A., Berg M., Lee J.H., Sato Y., Rao M.V., Mohan P.S., et al. Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in&#xa0;vivo. Mol. Psychiatr. 2015;20:986&#x2013;994. doi: 10.1038/mp.2015.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.45</ArticleId><ArticleId IdType="pmc">PMC4514553</ArticleId><ArticleId IdType="pubmed">25869803</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridel C., van Wieringen W.N., Zetterberg H., Tijms B.M., Teunissen C.E., NFL Group. Alvarez-Cerme&#xf1;o J.C., Andreasson U., Axelsson M., B&#xe4;ckstr&#xf6;m D.C., et al. Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol. 2019;76:1035&#x2013;1048. doi: 10.1001/jamaneurol.2019.1534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.1534</ArticleId><ArticleId IdType="pmc">PMC6580449</ArticleId><ArticleId IdType="pubmed">31206160</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N., Ashton N.J., Andersson L.-M., Yilmaz A., Lindh M., Nilsson S., Price R.W., Blennow K., Zetterberg H., Gissl&#xe9;n M. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95:e1754&#x2013;e1759. doi: 10.1212/WNL.0000000000010111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010111</ArticleId><ArticleId IdType="pubmed">32546655</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R., Lor&#xe9; N.I., Finardi A., Mandelli A., Cirillo D.M., Tresoldi C., Benedetti F., Ciceri F., Rovere-Querini P., Comi G., et al. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients. J.&#xa0;Neurol. 2021;268:4436&#x2013;4442. doi: 10.1007/s00415-021-10595-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10595-6</ArticleId><ArticleId IdType="pmc">PMC8108733</ArticleId><ArticleId IdType="pubmed">33973106</ArticleId></ArticleIdList></Reference><Reference><Citation>Dheen S.T., Kaur C., Ling E.-A. Microglial activation and its implications in the brain diseases. Curr. Med. Chem. 2007;14:1189&#x2013;1197. doi: 10.2174/092986707780597961.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986707780597961</ArticleId><ArticleId IdType="pubmed">17504139</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivanti A.J., Vauloup-Fellous C., Prevot S., Zupan V., Suffee C., Do Cao J., Benachi A., De Luca D. Transplacental transmission of SARS-CoV-2 infection. Nat. Commun. 2020;11:3572. doi: 10.1038/s41467-020-17436-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17436-6</ArticleId><ArticleId IdType="pmc">PMC7360599</ArticleId><ArticleId IdType="pubmed">32665677</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhatbar C., Prinz M. The roles of microglia in viral encephalitis: from sensome to therapeutic targeting. Cell. Mol. Immunol. 2021;18:250&#x2013;258. doi: 10.1038/s41423-020-00620-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00620-5</ArticleId><ArticleId IdType="pmc">PMC7802409</ArticleId><ArticleId IdType="pubmed">33437050</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne L.G., Bouhaddou M., Reuschl A.-K., Zuliani-Alvarez L., Polacco B., Pelin A., Batra J., Whelan M.V.X., Hosmillo M., Fossati A., et al. Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature. 2022;602:487&#x2013;495. doi: 10.1038/s41586-021-04352-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04352-y</ArticleId><ArticleId IdType="pmc">PMC8850198</ArticleId><ArticleId IdType="pubmed">34942634</ArticleId></ArticleIdList></Reference><Reference><Citation>Schartz N.D., Tenner A.J. The good, the bad, and the opportunities of the complement system in neurodegenerative disease. J.&#xa0;Neuroinflammation. 2020;17:354. doi: 10.1186/s12974-020-02024-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-02024-8</ArticleId><ArticleId IdType="pmc">PMC7690210</ArticleId><ArticleId IdType="pubmed">33239010</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., Yamasaki R., Ransohoff R.M., Greenberg M.E., Barres B.A., Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691&#x2013;705. doi: 10.1016/j.neuron.2012.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.03.026</ArticleId><ArticleId IdType="pmc">PMC3528177</ArticleId><ArticleId IdType="pubmed">22632727</ArticleId></ArticleIdList></Reference><Reference><Citation>Severance E.G., Gressitt K.L., Buka S.L., Cannon T.D., Yolken R.H. Maternal complement C1q and increased odds for psychosis in adult offspring. Schizophr. Res. 2014;159:14&#x2013;19. doi: 10.1016/j.schres.2014.07.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.schres.2014.07.053</ArticleId><ArticleId IdType="pmc">PMC4177507</ArticleId><ArticleId IdType="pubmed">25195065</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y.W., Choi J.Y., Uyangaa E., Kim S.B., Kim J.H., Kim B.S., Kim K., Eo S.K. Distinct dictation of Japanese encephalitis virus-induced neuroinflammation and lethality via triggering TLR3 and TLR4 signal pathways. PLoS Pathog. 2014;10:e1004319. doi: 10.1371/journal.ppat.1004319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004319</ArticleId><ArticleId IdType="pmc">PMC4154777</ArticleId><ArticleId IdType="pubmed">25188232</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabouri A.H., Marcondes M.C.G., Flynn C., Berger M., Xiao N., Fox H.S., Sarvetnick N.E. TLR signaling controls lethal encephalitis in WNV-infected brain. Brain Res. 2014;1574:84&#x2013;95. doi: 10.1016/j.brainres.2014.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.05.049</ArticleId><ArticleId IdType="pmc">PMC4099315</ArticleId><ArticleId IdType="pubmed">24928618</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang T., Guo Y., Xu X., Zhao L., Shen X., Sun L., Xie P. BoDV-1 infection induces neuroinflammation by activating the TLR4/MyD88/IRF5 signaling pathway, leading to learning and memory impairment in rats. J.&#xa0;Med. Virol. 2021;93:6163&#x2013;6171. doi: 10.1002/jmv.27212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27212</ArticleId><ArticleId IdType="pubmed">34260072</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui W., Sun C., Ma Y., Wang S., Wang X., Zhang Y. Inhibition of TLR4 induces M2 microglial polarization and provides neuroprotection via the NLRP3 inflammasome in Alzheimer&#x2019;s disease. Front. Neurosci. 2020;14:444. doi: 10.3389/fnins.2020.00444.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00444</ArticleId><ArticleId IdType="pmc">PMC7251077</ArticleId><ArticleId IdType="pubmed">32508567</ArticleId></ArticleIdList></Reference><Reference><Citation>Balducci C., Frasca A., Zotti M., La Vitola P., Mhillaj E., Grigoli E., Iacobellis M., Grandi F., Messa M., Colombo L., et al. Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by &#x3b2;-amyloid oligomers in an acute mouse model of Alzheimer&#x2019;s disease. Brain Behav. Immun. 2017;60:188&#x2013;197. doi: 10.1016/j.bbi.2016.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2016.10.012</ArticleId><ArticleId IdType="pubmed">27751869</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan K., Khan S.A., Jalal K., Ul-Haq Z., Uddin R. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant. Virology. 2022;572:28&#x2013;43. doi: 10.1016/j.virol.2022.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2022.05.001</ArticleId><ArticleId IdType="pmc">PMC9087879</ArticleId><ArticleId IdType="pubmed">35576833</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Q., Zou Y., Liu H., Chen T., Zheng F., Huang Y., Chen C., Zhang Z. Toll-like receptor 4 deficiency ameliorates &#x3b2;2-microglobulin induced age-related cognition decline due to neuroinflammation in mice. Mol. Brain. 2020;13:20. doi: 10.1186/s13041-020-0559-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-0559-8</ArticleId><ArticleId IdType="pmc">PMC7023753</ArticleId><ArticleId IdType="pubmed">32059688</ArticleId></ArticleIdList></Reference><Reference><Citation>Okun E., Griffioen K.J., Lathia J.D., Tang S.-C., Mattson M.P., Arumugam T.V. Toll-like receptors in neurodegeneration. Brain Res. Rev. 2009;59:278&#x2013;292. doi: 10.1016/j.brainresrev.2008.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2008.09.001</ArticleId><ArticleId IdType="pmc">PMC2679904</ArticleId><ArticleId IdType="pubmed">18822314</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajishengallis G., Lambris J.D. More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation. Immunol. Rev. 2016;274:233&#x2013;244. doi: 10.1111/imr.12467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12467</ArticleId><ArticleId IdType="pmc">PMC5119927</ArticleId><ArticleId IdType="pubmed">27782328</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin Y.-R., Jiang J.-X., Hu Y., Pan J.-P., Mi X.-N., Gao Q., Xiao F., Zhang W., Luo H.-M. The immune system drives synapse loss during lipopolysaccharide-induced learning and memory impairment in mice. Front. Aging Neurosci. 2019;11:279. doi: 10.3389/fnagi.2019.00279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00279</ArticleId><ArticleId IdType="pmc">PMC6873885</ArticleId><ArticleId IdType="pubmed">31803043</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa J.M., Farr&#xe9;-Alins V., Ortega M.C., Navarrete M., Lopez-Rodriguez A.B., Palomino-Antol&#xed;n A., Fern&#xe1;ndez-L&#xf3;pez E., Vila-Del Sol V., Decouty C., Narros-Fern&#xe1;ndez P., et al. TLR4 pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury. Br. J. Pharmacol. 2021;178:3395&#x2013;3413. doi: 10.1111/bph.15488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15488</ArticleId><ArticleId IdType="pmc">PMC8453872</ArticleId><ArticleId IdType="pubmed">33830504</ArticleId></ArticleIdList></Reference><Reference><Citation>Semlali A., Al Mutairi M., Oqla Alanazi I., Awad Aljohi H., Reddy Parine N., Alhadheq A., Al-Jafari A.A., Mobeirek A.F., Al Amri A., Shaik J.P., et al. Toll-like receptor 4 polymorphisms in Saudi population with cardiovascular diseases. Mol. Genet. genomic Med. 2019;7:e852. doi: 10.1002/mgg3.852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mgg3.852</ArticleId><ArticleId IdType="pmc">PMC7650605</ArticleId><ArticleId IdType="pubmed">31328431</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K., Kant S., Singh V.K., Agrawal N.K., Gupta S.K., Singh K. Toll-like receptor 4 polymorphisms and their haplotypes modulate the risk of developing diabetic retinopathy in type 2 diabetes patients. Mol. Vis. 2014;20:704&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4037533</ArticleId><ArticleId IdType="pubmed">24883015</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Kim D.Y., Kim C.S., Kim H.J., Lee D.H., Lee H.M., Ko W., Lee G. The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men. Cancer Genet. Cytogenet. 2009;190:88&#x2013;92. doi: 10.1016/j.cancergencyto.2008.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cancergencyto.2008.12.011</ArticleId><ArticleId IdType="pubmed">19380025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerkhof M., Postma D.S., Brunekreef B., Reijmerink N.E., Wijga A.H., de Jongste J.C., Gehring U., Koppelman G.H. Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma. Thorax. 2010;65:690&#x2013;697. doi: 10.1136/thx.2009.119636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2009.119636</ArticleId><ArticleId IdType="pubmed">20685742</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferronato S., Gomez-Lira M., Menegazzi M., Diani E., Olivato S., Sartori M., Scuro A., Malerba G., Pignatti P.F., Romanelli M.G., Mazzucco S. Polymorphism -2604G&gt;A variants in TLR4 promoter are associated with different gene expression level in peripheral blood of atherosclerotic patients. J.&#xa0;Hum. Genet. 2013;58:812&#x2013;814. doi: 10.1038/jhg.2013.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jhg.2013.98</ArticleId><ArticleId IdType="pubmed">24108365</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Chatfield D.A., MPhil A.M., Jolly A., Trender W., Hellyer P.J., Giovane M.D., Newcombe V.F.J., Outtrim J.G., Warne B., et al. Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort. EClinicalMedicine. 2022;47:101417. doi: 10.1016/j.eclinm.2022.101417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101417</ArticleId><ArticleId IdType="pmc">PMC9048584</ArticleId><ArticleId IdType="pubmed">35505938</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Manukyan P., Deviaterikova A., Velichkovsky B.B., Kasatkin V. The impact of mild COVID-19 on executive functioning and mental health outcomes in young adults. Healthcare (Basel) 2022;10 doi: 10.3390/healthcare10101891. 1891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10101891</ArticleId><ArticleId IdType="pmc">PMC9601355</ArticleId><ArticleId IdType="pubmed">36292338</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmuth J., Barnett T.A., Asken B.M., Kelly J.D., Torres L., Stephens M.L., Greenhouse B., Martin J.N., Chow F.C., Deeks S.G., et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J.&#xa0;Neurovirol. 2021;27:191&#x2013;195. doi: 10.1007/s13365-021-00954-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00954-4</ArticleId><ArticleId IdType="pmc">PMC7852463</ArticleId><ArticleId IdType="pubmed">33528824</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G.-I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.-A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Apple A.C., Oddi A., Peluso M.J., Asken B.M., Henrich T.J., Kelly J.D., Pleasure S.J., Deeks S.G., Allen I.E., Martin J.N., et al. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann. Clin. Transl. Neurol. 2022;9:221&#x2013;226. doi: 10.1002/acn3.51498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51498</ArticleId><ArticleId IdType="pmc">PMC8862406</ArticleId><ArticleId IdType="pubmed">35043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.-L., Abiona O., Graham B.S., McLellan J.S. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260&#x2013;1263. doi: 10.1126/science.abb2507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvim R.G.F., Lima T.M., Rodrigues D.A.S., Marsili F.F., Bozza V.B.T., Higa L.M., Monteiro F.L., Abreu D.P.B., Leit&#xe3;o I.C., Carvalho R.S., et al. From a recombinant key antigen to an accurate, affordable serological test: lessons learnt from COVID-19 for future pandemics. Biochem. Eng. J. 2022;186:108537. doi: 10.1016/j.bej.2022.108537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bej.2022.108537</ArticleId><ArticleId IdType="pmc">PMC9287463</ArticleId><ArticleId IdType="pubmed">35874089</ArticleId></ArticleIdList></Reference><Reference><Citation>Gim&#xe9;nez-Garz&#xf3; C., Fiorillo A., Ballester-Ferr&#xe9; M.P., Gallego J.-J., Casanova-Ferrer F., Urios A., Benlloch S., Mart&#xed;-Aguado D., San-Miguel T., Tosca J., et al. A new score unveils a high prevalence of mild cognitive impairment in patients with nonalcoholic fatty liver disease. J.&#xa0;Clin. Med. 2021;10:2806. doi: 10.3390/jcm10132806.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132806</ArticleId><ArticleId IdType="pmc">PMC8268962</ArticleId><ArticleId IdType="pubmed">34202269</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenfield E.A. Sampling and preparation of mouse and rat serum. Cold Spring Harb. Protoc. 2017;2017 doi: 10.1101/pdb.prot100271. pdb.prot100271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/pdb.prot100271</ArticleId><ArticleId IdType="pubmed">29093207</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz L.P., Almeida J.C., Tortelli V., Vargas Lopes C., Setti-Perdig&#xe3;o P., Stipursky J., Kahn S.A., Rom&#xe3;o L.F., de Miranda J., Alves-Leon S.V., et al. Astrocyte-induced synaptogenesis is mediated by transforming growth factor &#x3b2; signaling through modulation of D-serine levels in cerebral cortex neurons. J.&#xa0;Biol. Chem. 2012;287:41432&#x2013;41445. doi: 10.1074/jbc.M112.380824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.380824</ArticleId><ArticleId IdType="pmc">PMC3510841</ArticleId><ArticleId IdType="pubmed">23055518</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellesi M., de Vivo L., Chini M., Gilli F., Tononi G., Cirelli C. Sleep loss promotes astrocytic phagocytosis and microglial activation in mouse cerebral cortex. J.&#xa0;Neurosci. 2017;37:5263&#x2013;5273. doi: 10.1523/JNEUROSCI.3981-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3981-16.2017</ArticleId><ArticleId IdType="pmc">PMC5456108</ArticleId><ArticleId IdType="pubmed">28539349</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Rodriguez A.B., Siopi E., Finn D.P., Marchand-Leroux C., Garcia-Segura L.M., Jafarian-Tehrani M., Viveros M.-P. CB1 and CB2 cannabinoid receptor antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice. Cerebr. Cortex. 2015;25:35&#x2013;45. doi: 10.1093/cercor/bht202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bht202</ArticleId><ArticleId IdType="pubmed">23960212</ArticleId></ArticleIdList></Reference><Reference><Citation>Helgason C.D., Miller C.L., Helgason C.D. 2004. Basic Cell Culture Protocols.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>